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Figure 4 Microscopic examination. (A) The multicystic mass had a thick fibrous wall with cuticula. (B) There were invaginated
scolices with hooklets.
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doi:10.1016/j.ijid.2007.12.016Isolated orbital mucormycosis: a rare presenta-
tion ending in a fatal outcome
A 71-year-old male presented to the hospital because of
ataxia and numbness of the lower extremities. The patient
had a prior history of diabetes mellitus and chronic atrial
fibrillation, and received warfarin analogues. A computed
tomography (CT) of the spine disclosed osteolytic bone
lesions at the level of the 5th thoracic vertebra and a soft
tissue paravertebral mass, accompanied by compression
phenomena. Spondylectomy with wide resection was per-
formed and reversed clinical symptoms. Histologic material
revealed the presence of aggressive non-Hodgkin lymphoma
of diffuse large B-cell (DLCBL) type. The patient was HIV
seronegative. The disease was confined only to the thoracic
vertebra, and the patient received combined chemotherapy(cyclophosphamide, mitoxantrone, vincristine, and predni-
sone — CNOP regimen) along with local radiotherapy, and
was scheduled to receive the second chemotherapy course
21 days later.
The patient was readmitted (day 1) with sudden loss of
vision of the right eye, edema, ptosis and exophalmus, and
ophthalmoplegia. Amagnetic resonance imaging (MRI) of the
orbit revealed the presence of bilateral soft tissue masses,
mainly at the right side (day 2). Fundoscopic examinations
were unremarkable suggesting ischemia, and otorhinolar-
yngologic evaluation was also unremarkable. Cerebrospinal
fluid was not informatory. As bacterial orbital cellulitis and
lymphoma of the orbit were considered the most probable
diagnoses, the patient was empirically covered with broad-
spectrum intravenous antibiotics (imipenem and vancomy-
cin) and received intravenous high dose methotrexate to
Figure 1 (A) Magnetic resonance imaging (MRI), axial T1, gadolinium-enhanced image. Progression of the infiltrating lesion of the
right orbit. Similar lesion at the left orbit. (B) MRI, axial FLAIR image. Paranasal sinuses appear normal. (C) Mucor hyphae. Gomori’s
methenamine-silver (GMS) stain. (D) MRI, axial FLAIR image. Extension of the lesions intracranially, involving both frontal lobes and the
right temporal lobe.
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needle aspiration however was inconclusive. As invasive
mycosis was still in the differential diagnosis, a second
MRI was performed (day 9) and confirmed the previous
findings (Figure 1A) along with the absence of paranasal
sinus involvement, bone destructive process (Figure 1B),
and cerebral involvement. Mucormycosis was considered a
remote possibility. Local recurrence of lymphoma and rare
causes of orbital involvement such as sarcoidosis of the eye
and Wegener’s granulomatosis were added to the differen-
tial diagnosis.
An emergent surgical debridement of the orbit under
general anesthesia was postponed because of coexistent
comorbidities. Extensive surgical debridement was finally
performed and pathologic studies showed fungal hyphae,
establishing the diagnosis of mucormycosis (Figure 1C). Lipo-
somal amphotericin and posaconazole were initiated. How-
ever, the patient progressed rapidly, within days, to lethargy
and coma and was admitted to the intensive care unit. A new
MRI (day 44) revealed diffuse involvement of the brain
parenchyma (Figure 1D), leading finally to a fatal outcome
(day 51) in multiorgan failure.
Mucormycosis is an invasive, opportunistic fungal infec-
tion usually seen in immunocompromised patients, and par-
ticularly in the setting of diabetes or immune deficiency. It
has also been associated with hematologic malignancies,
with the most frequent sites of infection being lung and
orbito-sinus-facial anatomic structures. Cerebral involve-
ment has always been found associated with other sites of
infection.1 It is assumed that the port of entry is colonization
of the nasal mucosa, allowing the fungus to spread via the
paranasal sinuses into the orbit. Involvement of the brain and
cavernous sinus occurs by way of the orbital apex; therefore,
sphenoethmoidectomy with or without maxillectomy seems
to be the definitive method to eradicate this infection. The
pterygopalatine fossa is considered to be the main reservoir
for rhinocerebral mucormycosis, and extension into the orbit
and facial soft tissues usually follows this route. After pro-
liferation in the nasal cavity, the mucor reaches the pter-
ygopalatine fossa, inferior orbital fissure, and finally the
retroglobal space of the orbit, resulting in ocular signs.
The facial soft tissues, palate, and infratemporal fossa can
be infected through connecting pathways from the pterygo-
palatine fossa; therefore, debridement of the pterygopala-tine fossa seems to be the definitive method of managing this
infection.2 Our patient presented with typical symptoms of
ophthalmic involvement that characterize cerebro-rhino-
orbital phycomycosis (CROP) but without clinical or radiolo-
gical evidence of paranasal sinus involvement, which was a
uniform finding in patients with diabetes.3 Cerebral involve-
ment occurred later in the disease course, leading to rapid
clinical deterioration and largely determined the fatal
outcome.
Isolated cerebral mucormycosis, without evidence of
nasal sinus, orbital, or other primary locus of fungus infection
has been a rarity, mainly confined to intravenous drug users.4
To our knowledge, isolated orbital mucormycosis has not
been described so far. This rare clinical presentationmodified
diagnostic evaluation, delayed rapid diagnosis, and required
amore invasive diagnostic approach to identify the infectious
cause, as the differential diagnosis initially included lym-
phoma with ocular involvement5 and other rare causes of
granulomatous orbital lesions,6 including sarcoidosis, Wege-
ner’s disease, and tuberculosis.
Therapy includes treatment of the underlying disease,
surgical excision of the necrotic tissue, and the systemic
administration of amphotericin B. Posaconazole and ravuco-
nazole have good activity in vitro. However, the overall rate
of mortality of mucormycosis remains high, especially when
correct diagnosis is delayed.
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doi:10.1016/j.ijid.2008.01.015Oral paracoccidioidomycosis and pulmonary
tuberculosis co-infection: relevance of oral
biopsy in establishing the diagnosis and thera-
peutic approach
We report herein a case of concomitant oral paracoccidioi-
domycosis (PCM) and pulmonary tuberculosis (TB) infection in
a Brazilian patient. This paper highlights the relevance of
clinical and laboratory evaluation of oral lesions in the pre-
vention, early diagnosis, and treatment of pulmonary dis-
eases. Oral lesions are usually more accessible for sampling
and can be an important marker for pulmonary fungal and
bacterial illnesses.
A 47-year-old Caucasian male patient was referred to the
Oral Medicine Reference Unit by his infectious disease spe-
cialist, due to a medical history of a 5-month painful oro-
pharyngeal ulcer associated with recent weight loss,
coughing, and difficulty swallowing. Physical examination
revealed a bilateral submandibular lymph node enlargement,
and during intra-oral examination, an extensive erythema-
tous and granulomatous soft palate ulcer involving the uvula
and the oropharynx was observed (Figure 1).
The patient reported smoking (20 cigarettes/day for 25
years) and occasional weekly alcohol consumption, but no
other drug use. He reported taking part in rural activities,
mainly agricultural, from 14 to 35 years of age. An initialdiagnosis of oral squamous cell carcinoma or paracoccidioi-
domycosis was established. An oral biopsy was immediately
performed of the soft palate ulcer. Acid-fast bacilli (AFB)
sputum investigation, anti-HIV antibodies by ELISA testing,
and a chest radiograph were also requested. Radiograph
images confirmed the diagnosis of tuberculosis with pulmon-
ary involvement (Figure 2), and the sputum AFB was positive.
The anti-HIV test was negative.
Tuberculosis treatment was initiated with daily adminis-
tration of rifampin, isoniazid, and pyrazinamide (RIP). His-
tological analysis of the oral sample performed after initialFigure 2 Evidence of parenchymatous infiltrate compatible
with tuberculosis on chest X-ray, confirmed by acid-fast bacilli
(AFB) sputum analysis.
